Intermittent Fasting on Body Fat and Quality of Life
Launched by LOMA LINDA UNIVERSITY · Mar 5, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how intermittent fasting might help people lose body fat and improve their quality of life. Intermittent fasting is a way of eating where you cycle between periods of eating and fasting. The researchers want to see if this method is safe and effective for healthy individuals.
To participate in this trial, you need to be generally healthy and between the ages of 65 and 74. However, if you have diabetes or metabolic syndrome, you won't be able to join. If you do take part, you can expect guidance on how to follow an intermittent fasting schedule and share your experiences about how it affects your body and daily life. The study is currently looking for new participants, and your involvement could help us understand more about the benefits of intermittent fasting.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • In good health
- Exclusion Criteria:
- • • Diabetes or Metabolic Syndrome
About Loma Linda University
Loma Linda University is a prominent academic institution dedicated to advancing health and wellness through innovative research and education. As a sponsor of clinical trials, Loma Linda University leverages its extensive medical and scientific expertise to conduct rigorous studies aimed at improving patient outcomes and public health. With a commitment to ethical practices and patient safety, the university collaborates with a diverse network of healthcare professionals and researchers to explore novel therapeutic interventions and enhance clinical knowledge across various medical disciplines. Through its clinical trials, Loma Linda University seeks to contribute valuable insights to the medical community and foster advancements in healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Loma Linda, California, United States
Patients applied
Trial Officials
Gurinder Bains, PhD
Principal Investigator
Loma Linda University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported